Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07290738 · ClinicalTrials.gov registry record · NA
Transcranial Magnetic Stimulation (TMS) for Negative Symptoms in Schizophrenia Spectrum Disorders
A NA study, sponsored by The University of Texas Health Science Center, Houston.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT07290738 is a NA study that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 20 participants.
The verdict
NCT07290738, a NA study, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if repetitive transcranial magnetic stimulation (rTMS) applied to angular gyrus (AG) will improve negative symptoms and/or other psychosis symptoms in schizophrenia spectrum disorders (SSD) patients compared with prefrontal cortex (PFC) or sham.
Interventions
- DEVICE TMS
- DEVICE sham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-03-13 |
| Est. Completion | 2030-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07290738
The ClinicalTrials.gov registry entry for NCT07290738 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which TMS is the first listed.
NCT07290738 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07290738 about?
NCT07290738 is a clinical study titled "Transcranial Magnetic Stimulation (TMS) for Negative Symptoms in Schizophrenia Spectrum Disorders". The purpose of this study is to determine if repetitive transcranial magnetic stimulation (rTMS) applied to angular gyrus (AG) will improve negative symptoms and/or other psychosis symptoms in schizophrenia spectrum disorders (SSD) patients compared with prefrontal cortex (PFC) or sham.
What is the current status of trial NCT07290738?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2026-03-13. Estimated completion is 2030-11-30.
What interventions are being tested in trial NCT07290738?
The interventions under investigation include: TMS (DEVICE), sham (DEVICE).
Who is sponsoring clinical trial NCT07290738?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.